Do’s and Dont’s while facing the increased war for talent.
A lot is happening in the world of Pharmaceuticals these days. Just as big pharma witnessed a lot of consolidation in the mid-late 2000s, the last few years have been the age of small- to mid-sized biotech/ pharmaceutical companies as they scale up for rapid growth. This is leading to some interesting challenges for them on the business and people front. The three realities facing the pharmaceutical industry today are:
The sector is scaling rapidly and there are hyper-inflated talent markets where demand exceeds supply
The small and mid-sized pharmaceutical industry is in the midst of some fascinating growth and change. Those with a strong pipeline, situated in the hot talent markets of Cambridge, MA, Dublin, Ireland, or New Jersey amongst others are seeing some exciting growth opportunities and similar talent challenges. While some might be on the verge of a rich pipeline, others are witnessing a move to commercialization all of which calls for scaling of talent processes at a speed that has not been seen before.
Employees want career progression and are not shy about moving companies for better pay and titles
The employee who is comfortably located in these markets with the right skills and experience is suddenly seeing the market open up with opportunities that present greater career choices along with significant powers to negotiate their way in. What they want is rapid career progression with the right pay that maintains their brand worth both from an internal and external equity standpoint. More importantly, no one is feeling shy in making demands on the titles they would like to see on their business cards.
Employers often succumb to pressures of attraction and retention in ways that might be causing bigger issues to organization design and employee morale
What the reality of the market and the employee needs means for the employer is a daily challenge on the attraction and retention front. Several companies find themselves with organizational bulges at the VP and director levels as skilled talent refuses to settle for anything less joining their company. This sets off a wave of internal angst and inequity as current employees feel disenfranchised if they feel the person being brought in negotiated their way to a higher title.
As organizations deal with these challenges, there are several steps or missteps that can propel them to a business advantage or disadvantage very quickly. Below are a few Do's and Don'ts as you look at this problem and try to solve it for your organization.
This is a dynamic sector which will only see more talent opportunities and challenges in the years to come. Setting the HR processes and approaches right from the beginning will be the key to success, not just for the organization itself but the industry as a whole.
Tonushree Mondal is talent, culture, and leadership consultant for her company Tonushree Mondal.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.